Literature DB >> 25711655

The financial burden of cancer patients: time to stop averting our eyes.

Barry R Meisenberg1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25711655     DOI： 10.1007/s00520-015-2664-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  15 in total

1.  Cents and sensitivity--teaching physicians to think about costs.

Authors:  Lisa Rosenbaum; Daniela Lamas
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

2.  Full disclosure--out-of-pocket costs as side effects.

Authors:  Peter A Ubel; Amy P Abernethy; S Yousuf Zafar
Journal:  N Engl J Med       Date:  2013-10-17       Impact factor: 91.245

3.  Cancer therapy costs influence treatment: a national survey of oncologists.

Authors:  Peter J Neumann; Jennifer A Palmer; Eric Nadler; Chihui Fang; Peter Ubel
Journal:  Health Aff (Millwood)       Date:  2010 Jan-Feb       Impact factor: 6.301

4.  Economist: It's time for tough choices on US health costs.

Authors:  Bridget M Kuehn
Journal:  JAMA       Date:  2014-06-25       Impact factor: 56.272

Review 5.  Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.

Authors:  Deborah Schrag; Morgan Hanger
Journal:  J Clin Oncol       Date:  2007-01-10       Impact factor: 44.544

6.  Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis.

Authors:  Veena Shankaran; Sanjay Jolly; David Blough; Scott D Ramsey
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

7.  Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.

Authors:  Scott R Berry; Chaim M Bell; Peter A Ubel; William K Evans; Eric Nadler; Elizabeth L Strevel; Peter J Neumann
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

8.  Patients' expectations about effects of chemotherapy for advanced cancer.

Authors:  Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

9.  Financial and family burden associated with cancer treatment in Ontario, Canada.

Authors:  Christopher J Longo; Margaret Fitch; Raisa B Deber; A Paul Williams
Journal:  Support Care Cancer       Date:  2006-05-30       Impact factor: 3.359

10.  Medical costs and productivity losses of cancer survivors--United States, 2008-2011.

Authors:  Donatus U Ekwueme; K Robin Yabroff; Gery P Guy; Matthew P Banegas; Janet S de Moor; Chunyu Li; Xuesong Han; Zhiyuan Zheng; Anita Soni; Amy Davidoff; Ruth Rechis; Katherine S Virgo
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-06-13       Impact factor: 17.586
View more
  2 in total

1.  Financial toxicity and symptom burden: what is the big deal?

Authors:  Raymond Javan Chan; Louisa Gordon; Syed Yousuf Zafar; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2018-02-13       Impact factor: 3.603

Review 2.  Patient-reported outcome measures of the impact of cancer on patients' everyday lives: a systematic review.

Authors:  Susan Catt; Rachel Starkings; Valerie Shilling; Lesley Fallowfield
Journal:  J Cancer Surviv       Date:  2016-11-10       Impact factor: 4.442
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.